Oral Answers to Questions

Debate between Michelle Donelan and Philippa Whitford

Monday 21st June 2021 Commons Chamber

[Michelle Donelan]

The hon. Member touched on a number of points, including workforce and talent within the UK in our universities. Through the introduction of the new skilled worker and global talent route, the UK is actually giving top priority to those with the highest skills and the greatest talents, including researchers, scientists and academics to join our world-leading higher education sector. The global talent route ensures that highly skilled individuals, including scientists and researchers, can come to the UK and make an important contribution.

[Dr Philippa Whitford (Central Ayrshire) (SNP)]

What recent discussions he has had with Cabinet colleagues on the allocation of Government funding to academic institutions for research.

[The Minister for Universities (Michelle Donelan)]

The Government are investing £14.9 billion on research and development in 2021-22, the highest level for four decades. The Department for Business, Energy and Industrial Strategy provides funding for academic researchers through UK Research and Innovation and the national academies, and published detailed allocations in May. I will continue to work closely with the Minister with responsibility for science, research and innovation, the Under-Secretary of State for Business, Energy and Industrial Strategy, my hon. Friend the Member for Derby North (Amanda Solloway).

[Dr Whitford [V]]

The UKRI’s global challenges research fund was set up to promote international collaboration on global issues, including climate change and health. However, due to the reduction in overseas aid, the funding promised in 2019 has now been cut in half, causing projects to be cancelled and researchers in low-income countries to be made redundant. In many cases, the last two years of research will be wasted. How will the Minister get academics to commit time and energy in the future, when they cannot trust this Government to honour their commitments?

[Michelle Donelan]

The changes to the level of official development assistance quality-related funding made available to universities has been applied equally across the four nations of the Union, as the hon. Member will know. The Government’s research ODA spend includes the global challenges research fund, which has been allocated in line with the thematic, rather than geographic, priorities of the strategic framework for UK ODA, as outlined by my right hon. Friend the Foreign Secretary, while prioritising high-value-for-money projects and existing legal commitments. I will be delighted to meet the hon. Member along with my hon. Friend the Under-Secretary responsibility for science, innovation and research to discuss this matter further.

Oral Answers to Questions

Debate between Michelle Donelan and Philippa Whitford

Monday 2nd March 2020 Commons Chamber

[The Minister for Universities (Michelle Donelan)]

I stress that the UK remains open to participation in elements of Erasmus+ on a time-limited basis, provided that the terms are in the UK’s interests. The UK will consider a relationship in line with non-EU member state participation in certain EU programmes, including Horizon Europe.

[Dr Whitford]

As the Minister says herself, the proposal for the future EU relationship suggests that the Government will take part in only certain elements of Erasmus+ and only for a time-limited period. Will she explain what it is about the Erasmus+ scheme that the Secretary of State thinks is not beneficial? Why on earth would participation be on just a temporary basis?

GP Recruitment and Retention

Debate between Michelle Donelan and Philippa Whitford

Wednesday 28th March 2018 Westminster Hall

[Dr Whitford]

I absolutely agree. As I have said, it is not particularly an issue in Scotland, but it is very much one in England. I know that it is being looked at under the new contract. Hon. Members may remember the Prime Minister’s challenge fund: extra surgeries at the weekend are better paid and do not involve the same indemnity issues as going to do a stint at the local out-of-hours. Unconsidered consequences of that kind must be looked at.

There is obviously increasing demand. We talk negatively about the ageing population, but living longer is a good thing, and I would like to recommend it. I spent 30 years trying to achieve it. In Scotland the number of GPs increased by 9% between 2005 and 2015, but the number of patients over 65 increased by 18%. Obviously, much innovation across the UK is to do with trying to reduce workload. Scotland was first to get rid of the quality and outcomes framework, which had encouraged significant quality improvements but grew into a huge bureaucratic machine. We are working on developing the multi- disciplinary team, with physios, access to counsellors, and pharmacists. That is happening in England as well. One innovation in England is known as “time for care” and concerns extra training at the frontline—reception—to encourage triage of patients to the right member of the team. However, my attention has been caught by the development of a new app that allows patients to book appointments directly; that would remove the option for triage. It is important for innovations to be joined up.

We need to innovate and to use all community resources. Scotland has for 10 years had community pharmacies providing minor ailment services. Our optometrists are allowed to make direct referrals to hospital for cataracts, and now they treat 90% of all acute eye problems. Those are things that may at the moment be referred to general practice simply to ask for a letter to be passed on. That is a waste.

There has, obviously, been a climb in the number of practice vacancies, including in Scotland. Our whole-time equivalent has fallen, in the past three years, by 1.9%—in England the figure is 2.8%. There has been a 50% increase in the number of GPs taking early retirement, at the age of about 57. Some of that is because of the change in pension tax rules. The problem of having too big a pension is a nice one to have; however, if people who invested 40 years ago in very expensive added years are finding suddenly, as they approach retirement age, that that means they are accruing no further pension, we have a problem.

Brexit is definitely a threat. In Scotland, 3.5% of the health and social care workforce—and 5.8% of doctors—are from the EU. In London the figure is 14%. We know that 14% of EU doctors in Scotland, and 19% in England, are already in the process of leaving and, as has been said, that is simply because they feel unwelcome. As we have seen with the difficulty of getting tier 2 visas over the past four months, recruiting from outside the EU is a real issue. Businesses in London can increase someone’s salary to get past the limitations, but the NHS is not able to be so flexible.

[Michelle Donelan]

Does the hon. Lady agree that we also need to tackle social injustices to ensure that the most disadvantaged in our society have the confidence and know-how to pursue a medical career? Does she welcome Government programmes to tackle that?

[Dr Whitford]

I absolutely welcome them. Similarly, in Scotland the new graduate medical programme will take on people who have done other degrees, and that is particularly aimed at encouraging those people to go into general practice and rural practice.